Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abnormal, acetyl, AChE, Acinetobacter, Adherex, AEs, agonist, Alzheimer, antagonist, antitumor, Aposense, arm, Arpida, baumannii, bind, binding, biopharma, Black, Blanchette, blank, Box, breakdown, breast, BSBA, callable, Camptosar, capecitabane, capecitabine, catabolism, chain, characteristic, chart, check, chemotherapy, choline, cisapride, closeout, colorectal, conjugate, constipation, consummation, cornerstone, counterparty, CPA, cytotoxic, cytotoxicity, database, de, defibrotide, dehydrogenase, departure, depot, deterring, detrimental, dihydropyrimidine, disbursement, discovered, disorder, distancing, dopamine, DPD, dramatically, dyspepsia, ECG, economy, efficient, efficiently, Elion, emptying, eniluracil, enterprise, entrepreneur, eradication, esterase, evolve, Exbaq, faith, Fennec, Floyd, fluoropyrimidine, forgivable, forgiven, freedom, gastric, genetic, Gentium, geographic, Georgetown, GI, Gimeracil, globe, GMP, Gram, guided, headache, HFS, Honorable, inactivator, inflection, irinotecan, irritable, Israel, Jay, lender, leverage, linked, lipophilic, liposomal, living, lock, LV, magnitude, metastatic, metoclopramide, Michael, milder, monoclonal, monotherapy, mortgage, motility, MRSA, Neurologic, neurotoxicity, neutropenia, newer, nonclinical, notably, novo, obstruction, Onivyde, onset, outbreak, pancreatic, pandemic, passage, Paycheck, peak, penetration, plasma, PPP, preferentially, premium, pretreatment, properly, prucalopride, quarantine, rat, Refractory, registrar, Rockefeller, RSA, SBA, seasoned, seller, serial, SpA, spread, stool, suboptimal, syndrome, temporal, Teysuno, thought, thwart, Tract, tumor, UMAB, unique, unplanned, unwanted, upper, vitro, wider, Xeloda, xenograft, Yuhan
Removed:
absent, acceleration, affiliated, afford, Angstrom, appointed, Aradigm, Asian, Assistant, assumed, assumption, automatic, bridge, Bulletin, captioned, carried, Chimeric, clarification, composition, comprehensive, customary, cybersecurity, Darier, dealer, declaring, deductibility, defray, deliver, description, device, dispose, doubt, earliest, effecting, element, embedded, emerging, enactment, estate, exclusively, exempted, exemption, exercising, exhaust, existed, Exploration, feature, Gabriel, genz, greatly, Henstch, hinder, Hong, indexed, instrument, insufficient, Jed, JMG, JMW, July, Justin, Kong, lesser, limitation, limiting, Los, navigating, Oil, outlined, owing, owner, partnership, penny, Peregrine, preemptive, principally, provisional, radiation, real, recovery, regional, relied, remeasurement, remote, repayment, repurposed, reserved, resigned, restricting, retrospective, revise, Richland, RIF, round, SAB, Savient, secondary, send, shareholder, shell, signature, Spinnaker, suitability, supporting, TCJA, Thompson, twenty, undertaken, Unifund, unit, vaccine, viewed, vote, Washington, Yorke
Filing tables
Filing exhibits
Related press release
PCSA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement Numbers 333-233264 and 333-190697 on Form S-8 of our report, dated March 25, 2021, relating to the consolidated financial statements of Processa Pharmaceuticals, Inc. for the years ended December 31, 2020 and 2019 included in the Annual Report on Form 10-K of Processa Pharmaceuticals, Inc. for the year ended December 31, 2020.
/s/ BD & Co. | |
Owings Mills, MD | |
March 25, 2021 |